Global Pirarubicin Hydrochloride for Injection Market Growth 2022-2028

The report requires updating with new data and is sent in 48 hours after order is placed.

The global market for Pirarubicin Hydrochloride for Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Pirarubicin Hydrochloride for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Pirarubicin Hydrochloride for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Pirarubicin Hydrochloride for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Pirarubicin Hydrochloride for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Pirarubicin Hydrochloride for Injection players cover MicroBiopharm Japan, Lilly, Hisun Pharmaceuticals, Shenzhen Main Luck Pharmaceuticals and Hanhui and etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage

This latest report provides a deep insight into the global Pirarubicin Hydrochloride for Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Pirarubicin Hydrochloride for Injection market, with both quantitative and qualitative data, to help readers understand how the Pirarubicin Hydrochloride for Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:

The study segments the Pirarubicin Hydrochloride for Injection market and forecasts the market size by Type (10 mg and 20 mg,), by Application (Head and Neck Tumor, Breast Cancer, Acute Leukemia and Others), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type

• 10 mg
• 20 mg

Segmentation by application

• Head and Neck Tumor
• Breast Cancer
• Acute Leukemia
• Others

Segmentation by region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Major companies covered

• MicroBiopharm Japan
• Lilly
• Hisun Pharmaceuticals
• Shenzhen Main Luck Pharmaceuticals
• Hanhui
• Zhejiang Haizheng Pharmaceutical

Chapter Introduction

Chapter 1: Scope of Pirarubicin Hydrochloride for Injection, Research Methodology, etc.

Chapter 2: Executive Summary, global Pirarubicin Hydrochloride for Injection market size (sales and revenue) and CAGR, Pirarubicin Hydrochloride for Injection market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.

Chapter 3: Pirarubicin Hydrochloride for Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022

Chapter 4: Global Pirarubicin Hydrochloride for Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.

Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.

Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace

Chapter 10: Manufacturing cost structure analysis

Chapter 11: Sales channel, distributors, and customers

Chapter 12: Global Pirarubicin Hydrochloride for Injection market size forecast by region, by country, by type, and application.

Chapter 13: Comprehensive company profiles of the leading players, including MicroBiopharm Japan, Lilly, Hisun Pharmaceuticals, Shenzhen Main Luck Pharmaceuticals, Hanhui and Zhejiang Haizheng Pharmaceutical, etc.

Chapter 14: Research Findings and Conclusion

LIST OF TABLES

Table 1. Pirarubicin Hydrochloride for Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pirarubicin Hydrochloride for Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 10 mg
Table 4. Major Players of 20 mg
Table 5. Global Pirarubicin Hydrochloride for Injection Sales by Type (2017-2022) & (K Units)
Table 6. Global Pirarubicin Hydrochloride for Injection Sales Market Share by Type (2017-2022)
Table 7. Global Pirarubicin Hydrochloride for Injection Revenue by Type (2017-2022) & ($ million)
Table 8. Global Pirarubicin Hydrochloride for Injection Revenue Market Share by Type (2017-2022)
Table 9. Global Pirarubicin Hydrochloride for Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Pirarubicin Hydrochloride for Injection Sales by Application (2017-2022) & (K Units)
Table 11. Global Pirarubicin Hydrochloride for Injection Sales Market Share by Application (2017-2022)
Table 12. Global Pirarubicin Hydrochloride for Injection Revenue by Application (2017-2022)
Table 13. Global Pirarubicin Hydrochloride for Injection Revenue Market Share by Application (2017-2022)
Table 14. Global Pirarubicin Hydrochloride for Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Pirarubicin Hydrochloride for Injection Sales by Company (2020-2022) & (K Units)
Table 16. Global Pirarubicin Hydrochloride for Injection Sales Market Share by Company (2020-2022)
Table 17. Global Pirarubicin Hydrochloride for Injection Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Pirarubicin Hydrochloride for Injection Revenue Market Share by Company (2020-2022)
Table 19. Global Pirarubicin Hydrochloride for Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Pirarubicin Hydrochloride for Injection Producing Area Distribution and Sales Area
Table 21. Players Pirarubicin Hydrochloride for Injection Products Offered
Table 22. Pirarubicin Hydrochloride for Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pirarubicin Hydrochloride for Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Pirarubicin Hydrochloride for Injection Sales Market Share Geographic Region (2017-2022)
Table 27. Global Pirarubicin Hydrochloride for Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Pirarubicin Hydrochloride for Injection Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Pirarubicin Hydrochloride for Injection Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Pirarubicin Hydrochloride for Injection Sales Market Share by Country/Region (2017-2022)
Table 31. Global Pirarubicin Hydrochloride for Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Pirarubicin Hydrochloride for Injection Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Pirarubicin Hydrochloride for Injection Sales by Country (2017-2022) & (K Units)
Table 34. Americas Pirarubicin Hydrochloride for Injection Sales Market Share by Country (2017-2022)
Table 35. Americas Pirarubicin Hydrochloride for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Pirarubicin Hydrochloride for Injection Revenue Market Share by Country (2017-2022)
Table 37. Americas Pirarubicin Hydrochloride for Injection Sales by Type (2017-2022) & (K Units)
Table 38. Americas Pirarubicin Hydrochloride for Injection Sales Market Share by Type (2017-2022)
Table 39. Americas Pirarubicin Hydrochloride for Injection Sales by Application (2017-2022) & (K Units)
Table 40. Americas Pirarubicin Hydrochloride for Injection Sales Market Share by Application (2017-2022)
Table 41. APAC Pirarubicin Hydrochloride for Injection Sales by Region (2017-2022) & (K Units)
Table 42. APAC Pirarubicin Hydrochloride for Injection Sales Market Share by Region (2017-2022)
Table 43. APAC Pirarubicin Hydrochloride for Injection Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Pirarubicin Hydrochloride for Injection Revenue Market Share by Region (2017-2022)
Table 45. APAC Pirarubicin Hydrochloride for Injection Sales by Type (2017-2022) & (K Units)
Table 46. APAC Pirarubicin Hydrochloride for Injection Sales Market Share by Type (2017-2022)
Table 47. APAC Pirarubicin Hydrochloride for Injection Sales by Application (2017-2022) & (K Units)
Table 48. APAC Pirarubicin Hydrochloride for Injection Sales Market Share by Application (2017-2022)
Table 49. Europe Pirarubicin Hydrochloride for Injection Sales by Country (2017-2022) & (K Units)
Table 50. Europe Pirarubicin Hydrochloride for Injection Sales Market Share by Country (2017-2022)
Table 51. Europe Pirarubicin Hydrochloride for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Pirarubicin Hydrochloride for Injection Revenue Market Share by Country (2017-2022)
Table 53. Europe Pirarubicin Hydrochloride for Injection Sales by Type (2017-2022) & (K Units)
Table 54. Europe Pirarubicin Hydrochloride for Injection Sales Market Share by Type (2017-2022)
Table 55. Europe Pirarubicin Hydrochloride for Injection Sales by Application (2017-2022) & (K Units)
Table 56. Europe Pirarubicin Hydrochloride for Injection Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Pirarubicin Hydrochloride for Injection Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Pirarubicin Hydrochloride for Injection Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Pirarubicin Hydrochloride for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Pirarubicin Hydrochloride for Injection Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Pirarubicin Hydrochloride for Injection Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Pirarubicin Hydrochloride for Injection Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Pirarubicin Hydrochloride for Injection Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Pirarubicin Hydrochloride for Injection Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Pirarubicin Hydrochloride for Injection
Table 66. Key Market Challenges & Risks of Pirarubicin Hydrochloride for Injection
Table 67. Key Industry Trends of Pirarubicin Hydrochloride for Injection
Table 68. Pirarubicin Hydrochloride for Injection Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Pirarubicin Hydrochloride for Injection Distributors List
Table 71. Pirarubicin Hydrochloride for Injection Customer List
Table 72. Global Pirarubicin Hydrochloride for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Pirarubicin Hydrochloride for Injection Sales Market Forecast by Region
Table 74. Global Pirarubicin Hydrochloride for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Pirarubicin Hydrochloride for Injection Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Pirarubicin Hydrochloride for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Pirarubicin Hydrochloride for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Pirarubicin Hydrochloride for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Pirarubicin Hydrochloride for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Pirarubicin Hydrochloride for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Pirarubicin Hydrochloride for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Pirarubicin Hydrochloride for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Pirarubicin Hydrochloride for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Pirarubicin Hydrochloride for Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Pirarubicin Hydrochloride for Injection Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Pirarubicin Hydrochloride for Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Pirarubicin Hydrochloride for Injection Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Pirarubicin Hydrochloride for Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Pirarubicin Hydrochloride for Injection Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Pirarubicin Hydrochloride for Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Pirarubicin Hydrochloride for Injection Revenue Market Share Forecast by Application (2023-2028)
Table 92. MicroBiopharm Japan Basic Information, Pirarubicin Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. MicroBiopharm Japan Pirarubicin Hydrochloride for Injection Product Offered
Table 94. MicroBiopharm Japan Pirarubicin Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. MicroBiopharm Japan Main Business
Table 96. MicroBiopharm Japan Latest Developments
Table 97. Lilly Basic Information, Pirarubicin Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Lilly Pirarubicin Hydrochloride for Injection Product Offered
Table 99. Lilly Pirarubicin Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Lilly Main Business
Table 101. Lilly Latest Developments
Table 102. Hisun Pharmaceuticals Basic Information, Pirarubicin Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Hisun Pharmaceuticals Pirarubicin Hydrochloride for Injection Product Offered
Table 104. Hisun Pharmaceuticals Pirarubicin Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Hisun Pharmaceuticals Main Business
Table 106. Hisun Pharmaceuticals Latest Developments
Table 107. Shenzhen Main Luck Pharmaceuticals Basic Information, Pirarubicin Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Shenzhen Main Luck Pharmaceuticals Pirarubicin Hydrochloride for Injection Product Offered
Table 109. Shenzhen Main Luck Pharmaceuticals Pirarubicin Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Shenzhen Main Luck Pharmaceuticals Main Business
Table 111. Shenzhen Main Luck Pharmaceuticals Latest Developments
Table 112. Hanhui Basic Information, Pirarubicin Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Hanhui Pirarubicin Hydrochloride for Injection Product Offered
Table 114. Hanhui Pirarubicin Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Hanhui Main Business
Table 116. Hanhui Latest Developments
Table 117. Zhejiang Haizheng Pharmaceutical Basic Information, Pirarubicin Hydrochloride for Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Zhejiang Haizheng Pharmaceutical Pirarubicin Hydrochloride for Injection Product Offered
Table 119. Zhejiang Haizheng Pharmaceutical Pirarubicin Hydrochloride for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Zhejiang Haizheng Pharmaceutical Main Business
Table 121. Zhejiang Haizheng Pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Picture of Pirarubicin Hydrochloride for Injection
Figure 2. Pirarubicin Hydrochloride for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pirarubicin Hydrochloride for Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pirarubicin Hydrochloride for Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pirarubicin Hydrochloride for Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 10 mg
Figure 10. Product Picture of 20 mg
Figure 11. Global Pirarubicin Hydrochloride for Injection Sales Market Share by Type in 2021
Figure 12. Global Pirarubicin Hydrochloride for Injection Revenue Market Share by Type (2017-2022)
Figure 13. Pirarubicin Hydrochloride for Injection Consumed in Head and Neck Tumor
Figure 14. Global Pirarubicin Hydrochloride for Injection Market: Head and Neck Tumor (2017-2022) & (K Units)
Figure 15. Pirarubicin Hydrochloride for Injection Consumed in Breast Cancer
Figure 16. Global Pirarubicin Hydrochloride for Injection Market: Breast Cancer (2017-2022) & (K Units)
Figure 17. Pirarubicin Hydrochloride for Injection Consumed in Acute Leukemia
Figure 18. Global Pirarubicin Hydrochloride for Injection Market: Acute Leukemia (2017-2022) & (K Units)
Figure 19. Pirarubicin Hydrochloride for Injection Consumed in Others
Figure 20. Global Pirarubicin Hydrochloride for Injection Market: Others (2017-2022) & (K Units)
Figure 21. Global Pirarubicin Hydrochloride for Injection Sales Market Share by Application (2017-2022)
Figure 22. Global Pirarubicin Hydrochloride for Injection Revenue Market Share by Application in 2021
Figure 23. Pirarubicin Hydrochloride for Injection Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Pirarubicin Hydrochloride for Injection Revenue Market Share by Company in 2021
Figure 25. Global Pirarubicin Hydrochloride for Injection Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Pirarubicin Hydrochloride for Injection Revenue Market Share by Geographic Region in 2021
Figure 27. Global Pirarubicin Hydrochloride for Injection Sales Market Share by Region (2017-2022)
Figure 28. Global Pirarubicin Hydrochloride for Injection Revenue Market Share by Country/Region in 2021
Figure 29. Americas Pirarubicin Hydrochloride for Injection Sales 2017-2022 (K Units)
Figure 30. Americas Pirarubicin Hydrochloride for Injection Revenue 2017-2022 ($ Millions)
Figure 31. APAC Pirarubicin Hydrochloride for Injection Sales 2017-2022 (K Units)
Figure 32. APAC Pirarubicin Hydrochloride for Injection Revenue 2017-2022 ($ Millions)
Figure 33. Europe Pirarubicin Hydrochloride for Injection Sales 2017-2022 (K Units)
Figure 34. Europe Pirarubicin Hydrochloride for Injection Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Pirarubicin Hydrochloride for Injection Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Pirarubicin Hydrochloride for Injection Revenue 2017-2022 ($ Millions)
Figure 37. Americas Pirarubicin Hydrochloride for Injection Sales Market Share by Country in 2021
Figure 38. Americas Pirarubicin Hydrochloride for Injection Revenue Market Share by Country in 2021
Figure 39. United States Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Pirarubicin Hydrochloride for Injection Sales Market Share by Region in 2021
Figure 44. APAC Pirarubicin Hydrochloride for Injection Revenue Market Share by Regions in 2021
Figure 45. China Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Pirarubicin Hydrochloride for Injection Sales Market Share by Country in 2021
Figure 52. Europe Pirarubicin Hydrochloride for Injection Revenue Market Share by Country in 2021
Figure 53. Germany Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Pirarubicin Hydrochloride for Injection Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Pirarubicin Hydrochloride for Injection Revenue Market Share by Country in 2021
Figure 60. Egypt Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Pirarubicin Hydrochloride for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Pirarubicin Hydrochloride for Injection in 2021
Figure 66. Manufacturing Process Analysis of Pirarubicin Hydrochloride for Injection
Figure 67. Industry Chain Structure of Pirarubicin Hydrochloride for Injection
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles